L-base Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
L-base General Information
Description
Developer of an autophagy-targeted drug intended to overcome resistance to existing anticancer drugs. The company intends to develop therapeutic agents that can overcome resistance to targeted anticancer drugs using CAGE-derived peptides, helping patients reduce the possibility of side effects compared to the previous generation of chemotherapy.
Contact Information
Website
www.l-base.comCorporate Office
- Wangshimri-ro 58
- Seongdong-gu
- Seoul, 01415
- South Korea
Corporate Office
- Wangshimri-ro 58
- Seongdong-gu
- Seoul, 01415
- South Korea
L-base Timeline
L-base Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 21-May-2024 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 08-May-2024 | Completed | Startup | |||
| 5. Later Stage VC | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC (Series B) | 01-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 01-Jun-2018 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Nov-2016 | $529K | $529K | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
L-base Comparisons
Industry
Financing
Details
L-base Competitors (1)
One of L-base’s competitors is Deciphera Pharmaceuticals, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals | Formerly VC-backed | Waltham, MA |
L-base Patents
L-base Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023043271-A1 | Method for characterizing responder to cage inhibitor for cancer therapy | Inactive | 17-Sep-2021 | ||
| WO-2023043261-A1 | Pharmaceutical composition for enhancing anticancer effect of anticancer drug | Inactive | 17-Sep-2021 | ||
| US-20250213645-A1 | Pharmaceutical composition for modulating immune response | Pending | 17-Sep-2021 | ||
| WO-2023043269-A1 | Pharmaceutical composition for modulating immune response | Inactive | 17-Sep-2021 | ||
| JP-2023522311-A | Pharmaceutical composition for cancer prevention or treatment | Active | 22-Mar-2021 | C07K7/06 |
L-base Signals
L-base Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Seoul Biohub | Accelerator/Incubator | |||
| Korea Institute of Startup and Entrepreneurship Development | Accelerator/Incubator | |||
| Ministry of SMEs and Startups | Government | |||
| Daewon Pharmaceutical | Corporation | Minority | ||
| Mirakle Lab | Accelerator/Incubator | Minority |
L-base FAQs
-
When was L-base founded?
L-base was founded in 2015.
-
Where is L-base headquartered?
L-base is headquartered in Seoul, South Korea.
-
What is the size of L-base?
L-base has 3 total employees.
-
What industry is L-base in?
L-base’s primary industry is Drug Discovery.
-
Is L-base a private or public company?
L-base is a Private company.
-
What is L-base’s current revenue?
The current revenue for L-base is .
-
How much funding has L-base raised over time?
L-base has raised $10.5M.
-
Who are L-base’s investors?
Seoul Biohub, Korea Institute of Startup and Entrepreneurship Development, Ministry of SMEs and Startups, Daewon Pharmaceutical, and Mirakle Lab are 5 of 11 investors who have invested in L-base.
-
Who are L-base’s competitors?
Deciphera Pharmaceuticals is a competitor of L-base.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process